abstract |
The present invention provides a monoclonal antibody and an antigen-binding fragment thereof that specifically bind to CD20, and a pharmaceutical composition comprising the same. The invention also provides methods of using the monoclonal antibodies, antigen-binding fragments and pharmaceutical compositions in depleting B cells or treating B cell disorders, for example. Also provided are cells, nucleic acids and methods for producing said monoclonal antibodies. |